XIENCE XPEDITION 1074400-18Recalls & reported problems
Abbott Vascular Inc. · XIENCE Xpedition Everolimus Eluting Coronary Stent System 4.00 mm x 18 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE XPEDITION (41)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08717648162640), received between Mar 9, 2018 and Feb 13, 2020 — classified as 1 death, 1 malfunction.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Difficult to Remove1
- Improper or Incorrect Procedure or Method1
Patient problems
- Cardiac Arrest1
- Low Blood Pressure/ Hypotension1
- No Consequences Or Impact To Patient1
- Occlusion1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathFeb 13, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE 2.5X30 MM TREK DILATATION CATHETER WAS INFLATED THREE TIMES IN THE CALCIFIED MID LEFT ANTERIOR DESCENDING (LAD) CORONARY ARTERY. IT WAS INFLATED AT 14 ATMOSPHERES (ATMS), 20 ATMS AND 18 ATMS WHEN THE TREK RUPTURED. DURING REMOVAL OF THE TREK, THE BALLOON SEPARATED AND REMAINED IN THE ARTERY. ATTEMPTS MADE TO REMOVE/SNARE OUT THE SEPARATED SEGMENT OF THE TREK WERE NOT SUCCESSFUL. A VESSEL PERFORATION OCCURRED IN THE MID LAD DURING USE OF A NON-ABBOTT DILATATION CATHETER, BUT THE PATIENT REMAINED STABLE. THE 2.5X38 MM XIENCE XPEDITION STENT WAS DEPLOYED AT 12 ATMS FOR 15 SEC, THEN 12 ATM FOR 22 SEC, THEN 20 ATM FOR 15 SEC, AND 5 ATM FOR 11 SEC IN THE MID LAD OVER THE SEPARATED TREK BALLOON; HOWEVER, THE STENT DELIVERY SYSTEM (SDS) DID NOT FULLY DEFLATE AND WAS DIFFICULT TO REMOVE FROM THE GUIDE CATHETER, SO THE SDS AND GUIDE CATHETER WERE REMOVED TOGETHER AS A UNIT. THE PATIENT REMAINED STABLE. A 3.5X38 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE PROXIMAL LAD AND A 4.0X12 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE OSTIAL LEFT MAIN CORONARY ARTERY. A 4.0 X 18 MM XIENCE XPEDITION STENT WAS IMPLANTED IN THE PREDILATED LEFT MAIN TO LEFT CIRCUMFLEX. AFTER P
Patient problems: Cardiac Arrest; Low Blood Pressure/ Hypotension; Occlusion
MAUDE report 9707781 ↗MalfunctionMar 9, 2018Difficult to Remove; Improper or Incorrect Procedure or Method
IT WAS REPORTED THE PROCEDURE WAS PERFORMED TO TREAT A LESION IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). A PROWATER GUIDE WIRE WAS ADVANCED IN THE VESSEL. PRE-DILATATION WAS PERFORMED. A 4.0 X 18 MM XIENCE XPEDITION STENT WAS DEPLOYED AT THE TARGET LESION; HOWEVER, THE DEFLATED BALLOON COULD NOT BE WITHDRAWN INTO THE GUIDING CATHETER. ALL THE DEVICES WERE REMOVED AS A SINGLE UNIT INTO THE DESCENDING AORTA TO SAFELY APPLY FORCE TO RETRACT THE SDS AND IT WAS REMOVED FROM THE GUIDING CATHETER WITH A LOT OF RESISTANCE. POST-DILATATION WAS ACCOMPLISHED BY USING AN EXCHANGE WIRE AND RE-WIRING OF THE VESSEL WITH GOOD ANGIOGRAPHIC RESULTS. THERE WAS NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7328405 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page